Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001672659-26-000013 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 17, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
1,251
Total Value
$17,943.51
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Feb 17, 2026 | Exercise/Conversion | 417 | $15.44 | $6,438.48 | 44,506 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 17, 2026 | Sale | 417 | $27.59 | $11,505.03 | 44,089 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Feb 17, 2026 | Exercise/Conversion | 417 | $0.00 | $0.00 | 5,417 | Direct | โ | View Details |